Dr Bahlis is an Professor of Medicine at the University of Calgary in the division of Hematology and Bone Marrow Transplantation and a member of the Charbonneau Cancer Research Institute. Dr Bahlis received his medical degree in 1995 from St Joseph University - French Faculty of Medicine in Beirut. He then completed his internal Medicine residency at the State University of New York followed by a Hematology-Oncology fellowship at the University of Miami. Dr Bahlis also completed a postdoctoral fellowship in cancer biology at the University of Miami under the mentorship of Dr Lawrence Boise. Dr Bahlis’ clinical and laboratory research focus on the study of plasma cell dyscrasia, with particular interest in multiple myeloma genomics, drug resistance and the development of novel therapeutics. He has received several awards and research funding from numerous agencies including the ASCO young investigator award, Multiple Myeloma Research Foundation, Leukemia and Lymphoma Society, International Myeloma Society, Terry Fox Foundation and Canadian Institute of Health and Research. His research work was published in many peer-reviewed journals including New England Journal of Medicine, Nature Medicine, Cancer Cell, Blood, and Journal of Clinical Oncology. Dr Bahlis served on the American Society of Hematology plasma cell dyscrasia scientific committee and is currently serving as an associate editor for the Blood journal.